Allergy and Asthma
Blackwell Science Ltd (Verlag)
978-0-632-02239-7 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
Part 1 Lipid mediators and their antagonists: the future promise of agents which inhibit the formation and action of lipidmediators; agents which inhibit the 5-lipoxygenase and cycloxygebase pathways and their relationship to the treatment of allergic responses; leukotriene inhibitors and antagonists in asthma; platelet activing factor and biologically active acetylated phospholipids in asthma; pharmacological modulation of mediator generation and the allergic response by fish-oil diets; general discussion. Part 2 Modulating the specific immune response: prospects for modulation of the specific immune response in allergic diseases; new ideas on the preventions of allergy; suppression of the IgE response with human proteins developed by biotechnology; immunotherapy of asthma; general discussion. Part 3 Agents which supress inflammation: antiinflammatory agents in the treatment of bronchial asthma; nedocromil sodium - a review of its anti-inflammatory properties and critical activity in the treatment of asthma; cetizirene - a new selective H1-antagonist with effects on infiltrating inflammatory cells; lipocortinazelastine - a novel oral antiasthma compound with several modes of action; general discussion. Part 4 Concluding remarks: summing-up and general discussion.
| Erscheint lt. Verlag | 30.6.1989 |
|---|---|
| Zusatzinfo | 39 illustrations |
| Verlagsort | Oxford |
| Sprache | englisch |
| Gewicht | 504 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Dermatologie |
| Medizinische Fachgebiete ► Innere Medizin ► Pneumologie | |
| Naturwissenschaften ► Biologie ► Genetik / Molekularbiologie | |
| ISBN-10 | 0-632-02239-6 / 0632022396 |
| ISBN-13 | 978-0-632-02239-7 / 9780632022397 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
